| scholarly article | Q13442814 |
| P50 | author | Olivier Tenaillon | Q89436407 |
| Erick Denamur | Q92681607 | ||
| P2093 | author name string | Catherine Deschamps | |
| Ivan Matic | |||
| David Skurnik | |||
| Esthel Ronco | |||
| Catherine Branger | |||
| Bertrand Picard | |||
| Jean Louis Gaillard | |||
| P2860 | cites work | The population genetics of ecological specialization in evolving Escherichia coli populations | Q33922714 |
| Mutator clones of Neisseria meningitidis in epidemic serogroup A disease | Q34028018 | ||
| Mutator bacteria as a risk factor in treatment of infectious diseases | Q34113782 | ||
| High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. | Q34508854 | ||
| Mutators, population size, adaptive landscape and the adaptation of asexual populations of bacteria | Q34607018 | ||
| The consequences of growth of a mutator strain of Escherichia coli as measured by loss of function among multiple gene targets and loss of fitness | Q34609052 | ||
| Mismatch repair and response to DNA-damaging antitumour therapies | Q35548710 | ||
| Proliferation of mutators in A cell population | Q35618973 | ||
| Lethal mutagenesis of HIV. | Q36008905 | ||
| Dynamics of long-term colonization of respiratory tract by Haemophilus influenzae in cystic fibrosis patients shows a marked increase in hypermutable strains | Q37421041 | ||
| High frequency of mutator strains among human uropathogenic Escherichia coli isolates. | Q39694657 | ||
| Frequency of mutation to rifampin resistance in Streptococcus pneumoniae clinical strains: hexA and hexB polymorphisms do not account for hypermutation. | Q39743496 | ||
| Genetic background of Escherichia coli and extended-spectrum beta-lactamase type | Q41916268 | ||
| High Rate of Macrolide Resistance inStaphylococcus aureusStrains from Patients with Cystic Fibrosis Reveals High Proportions of Hypermutable Strains | Q44195004 | ||
| Hypermutable Haemophilus influenzae with mutations in mutS are found in cystic fibrosis sputum | Q45044337 | ||
| High mutation frequencies among Escherichia coli and Salmonella pathogens | Q48057867 | ||
| Role of mutator alleles in adaptive evolution. | Q54564129 | ||
| Costs and Benefits of High Mutation Rates: Adaptive Evolution of Bacteria in the Mouse Gut | Q56944626 | ||
| Highly Variable Mutation Rates in Commensal and Pathogenic Escherichia coli | Q56944671 | ||
| Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase | Q71095982 | ||
| Immune surveillance in colorectal carcinoma | Q72293575 | ||
| Hypermutation as a Factor Contributing to the Acquisition of Antimicrobial Resistance | Q79162727 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| multiple drug resistance | Q643839 | ||
| P304 | page(s) | 825-827 | |
| P577 | publication date | 2005-06-18 | |
| P1433 | published in | Genetics | Q3100575 |
| P1476 | title | Intermediate mutation frequencies favor evolution of multidrug resistance in Escherichia coli | |
| P478 | volume | 171 |
| Q36499090 | Antibiotic-resistant soil bacteria in transgenic plant fields |
| Q36905565 | Causes and consequences of DNA repair activity modulation during stationary phase in Escherichia coli |
| Q52627214 | Checks and balances? DNA replication and the cell cycle in Plasmodium. |
| Q42673777 | Competition between transposable elements and mutator genes in bacteria |
| Q28551519 | Evidence of a Mild Mutator Phenotype in Cambodian Plasmodium falciparum Malaria Parasites |
| Q28238561 | Evolution of mutation rates in bacteria |
| Q35960653 | Evolutionary origins of invasive populations |
| Q37957839 | Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens. |
| Q42738785 | Genome-wide analysis captures the determinants of the antibiotic cross-resistance interaction network. |
| Q39656697 | Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections |
| Q55285004 | High mutation rates limit evolutionary adaptation in Escherichia coli. |
| Q92141659 | Microbial Experimental Evolution - a proving ground for evolutionary theory and a tool for discovery |
| Q36683593 | Multiple Pathways of Genome Plasticity Leading to Development of Antibiotic Resistance. |
| Q33895328 | Noise-driven heterogeneity in the rate of genetic-variant generation as a basis for evolvability |
| Q34351963 | Parasitic plants have increased rates of molecular evolution across all three genomes |
| Q34426663 | Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms. |
| Q38270541 | Prevalence of hypermutators among clinical Acinetobacter baumannii isolates |
| Q21144990 | SOS response induces persistence to fluoroquinolones in Escherichia coli |
| Q38219786 | SOS, the formidable strategy of bacteria against aggressions. |
| Q37406333 | Side effects of antibiotics on genetic variability. |
| Q37166834 | Systematically Altering Bacterial SOS Activity under Stress Reveals Therapeutic Strategies for Potentiating Antibiotics |
| Q49320136 | The Odyssey of the Ancestral Escherich Strain through Culture Collections: an Example of Allopatric Diversification |
| Q38517985 | The balance between mutators and nonmutators in asexual populations |
| Q38665569 | Weak mutators can drive the evolution of fluoroquinolone resistance in Escherichia coli |
| Q36737307 | β-Lactam antibiotics promote bacterial mutagenesis via an RpoS-mediated reduction in replication fidelity |
Search more.